JENNIFER B YOUNG

Earlier government jobs, as reported

A lobbying report lists each lobbyist's covered positions: jobs in Congress or the executive branch that the law asks a lobbyist to disclose. Each line is copied as a report states it.

• Asst. Sec. for Leg. - HHS; Dep. Asst. Sec. for Leg. - HHS; Cmte. Staff, House Cmte. on Ways and Means; Cmte. Staff, Sen. Cmte. on Finance
• sst. Sec. for Leg. - HHS; Dep. Asst. Sec. for Leg. - HHS; Cmte. Staff, House Cmte. on Ways and Means; Cmte. Staff, Sen. Cmte. on Finance
• Asst. Sec. for Leg.- HHS; Dep. Asst. Sec for Leg. - HHS; Cmte. Staff, House Cmte. on Ways and Means; Cmte. Staff. Sen. Cmte. on Finance

Registrants and clients

• TARPLIN, DOWNS & YOUNG, LLC · 53 reports

Clients: ASTELLAS PHARMA US, INC; PHRMA; ABBOTT (FORMERLY KNOWN AS ALERE INC.); ABBVIE INC.; ADVAMED; ALZHEIMER'S ASSOCIATION; AMERICAN CANCER SOCIETY CANCER ACTION NETWORK (ACSCAN); AMERICAN OSTEOPATHIC ASSOCIATION; AMGEN INC; AMNEAL PHARMACEUTICALS, INC.; AMYLYX PHARMACEUTICALS; ASTRAZENECA; BIOTECHNOLOGY INDUSTRY ORGANIZATION; BLUE CROSS BLUE SHIELD ASSOCIATION; BOEHRINGER INGELHEIM; BREAKTHROUGH T1D (FKA JUVENILE DIABETES RESEARCH FOUNDATION INTERNATIONAL); BRISTOL MYERS SQUIBB; CARDINAL HEALTH (F.K.A. THE GLOVER PARK GROUP); ELEVANCE HEALTH, INC (F.K.A. ANTHEM, INC. & WELLPOINT, INC.); ELI LILLY AND COMPANY; EXCELLUS HEALTH PLAN, INC.; FLAGSHIP PIONEERING; FOUNDATION MEDICINE; GAINWELL TECHNOLOGIES (FKA HEALTH MANAGEMENT SYSTEMS); GENENTECH, INC.; GILEAD SCIENCES, INC.; H2 HEALTH; HANSA BIOPHARMA; HEALTH CARE SERVICE CORPORATION; HEALTHCARE DISTRIBUTION ALLIANCE (HEALTHCARE DISTRIBUTION MANAGMENT ASSN.); LINCARE; LOCAL HEALTH PLANS OF CALIFORNIA; LONGEVITY HEALTH PLAN; MERCK; NATIONAL COMPREHENSIVE CANCER NETWORK; NATIONAL SEATING & MOBILITY; NEUROCRINE BIOSCIENCES, INC.; NOVARTIS; NOVO NORDISK INC.; NOVOCURE INC.; PHREESIA; PRIORITY ON DEMAND; QUEST DIAGNOSTICS; REPLIMUNE INC.; SANOFI US SERVICES INC (FORMERLY KNOWN AS GENZYME CORPORATION); SAREPTA THERAPEUTICS; SAS; TERSERA THERAPEUTICS; TRIPLE-S MANAGEMENT CORPORATION; VERTEX PHARMACEUTICALS INCORPORATED; WHOOP.

Bills named where this lobbyist is listed, and how the House and the Senate voted

1 bill named in these reports. None of them became law in our record, so no recorded vote is shown. A lobbying report names the houses of Congress and the agencies the lobbyists contacted. It does not say which members or staff they met.

Issues named: Health Issues (48), Medicare/Medicaid (43), Budget/Appropriations (34), Taxation/Internal Revenue Code (4), Trade (domestic/foreign) (4), Pharmacy (1), Veterans (1).

Every report

Campaign gifts this lobbyist reported

Lobbyists and registrants report their political contributions twice a year (form LD-203). We hold these reports only for contributions to the campaign committees of members who sponsored or cosponsored a bill named in a lobbying report. Any other contribution: Not checked yet.

No contribution report we hold lists a gift from this filer.

Where this comes from

Lobbying Disclosure Act reports (LD-2), LDA.gov. We save our own copy of each page of LDA.gov's list of reports before we read it. These pages were built from our copies on October 18, 2026.

2026-Q2: every page of LDA.gov's list saved and read.

A lobbying report states the registrant's income from the client (a lobbying firm) or its own lobbying expenses (an organization lobbying for itself), for the whole quarter and every issue together. A report of less than $5,000, or of no lobbying activity, states no figure. It is not the amount spent on one bill.

Senate Office of Public Records cannot vouch for the data or analyses derived from these data after the data have been retrieved from LDA.gov.